Compare ESTA & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTA | LMAT |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2018 | 2006 |
| Metric | ESTA | LMAT |
|---|---|---|
| Price | $69.78 | $78.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $86.86 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 276.7K | 227.3K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 42.67 | 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | $61,208,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $28.05 | $14.21 |
| Revenue Next Year | $26.21 | $8.88 |
| P/E Ratio | ★ N/A | $55.67 |
| Revenue Growth | ★ 76.49 | 13.53 |
| 52 Week Low | $37.37 | $78.27 |
| 52 Week High | $97.59 | $118.01 |
| Indicator | ESTA | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 38.15 | 36.90 |
| Support Level | $64.11 | $78.65 |
| Resistance Level | $75.75 | $82.45 |
| Average True Range (ATR) | 2.89 | 1.69 |
| MACD | 0.22 | 0.40 |
| Stochastic Oscillator | 30.59 | 12.13 |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.